FOXD3 and neoplasm: Based on the findings of this study, we hypothesized that FOXD3-AS1 may affect the prognosis by regulating the immune microenvironment and tumor stemness in GBM and LGG, as well as having the potential to affect the efficacy of immunotherapy.